An error has been pointed out under the section CSF after our mini-review was published. At the end of the last paragraph, the reported correlations have been wrongly assigned to Alexandrov et al. The correct citation for this work is “Geekiyanage, H., and Chan, C. (2011). MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci. 31, 14820–14830. doi: 10.1523/JNEUROSCI.3883-11.2011.” However, these results were obtained from the study of frontal cortices of Alzheimer's patients, not the CSF. Thus, caution should be taken with regards to this work, which is unfortunately no longer in the scope of the present mini-review on circulating microRNAs as biomarkers.
Erratum: Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers
Veronique Dorval
*Correspondence: veronique.dorval@crchul.ulaval.ca
This article was submitted to the journal Frontiers in Molecular Neuroscience.
Edited by: Hermona Soreq, The Hebrew University of Jerusalem, Israel
Received 2013 Oct 23; Accepted 2013 Oct 24; Collection date 2013.
Keywords: microRNA, Alzheimer's disease, biomarker, diagnosis, mild cognitive impairment
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.